UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
New U.S. Patent reinforces competitive advantage and enables broader licensing and product opportunities across key